SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Baxter International (BAX)
BAX 21.06+1.8%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Uncle Mikey who started this subject10/16/2000 11:15:53 AM
From: Paul Lee   of 101
 
TWST: Baxter is rather well-known. What are the specific attributes that
you consider to be valuable?

Mr. Wittes: Baxter International (BAX) is a dominant player in the
hospital supply arena. A particularly large part of their business is
weighted toward the blood area ' which Baxter dominates. The stock has
risen nicely due to expectations for Factor VIII. Additionally, Baxter
is moving away from commodity-type hospital supply items into high-
margin specialty pharmaceutical items and vaccines.

TWST: Do you look at those additions as risk diversification or is it
really to bring in some high-growth diversification?

Mr. Wittes: I think it's multiple expansion. They are diversifying, but
into much higher growth arenas.

TWST: From the investors' viewpoint, should they be looking at these
particular stocks as part of their core holdings in the biotech, bio med
area or as part of a basket approach?

Mr. Wittes: I think Baxter should be a core holding, particularly when
they start to show some success with their biotech initiatives. In
addition, I think there are compelling reasons to buy the other names
that we've talked about.

TWST: Thank you. (DA)

JASON WITTES
UBS Warburg LLC
299 Park Avenue
New York, NY 10171-0026
(212) 821-3149
(212) 593-8632 - FAX
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext